Jason Throne, Chief Legal Officer at IDEAYA Biosciences, Inc. (IDYA), sold 5,574 shares at $30.03 ($167K) on 2023-09-05, disclosed to the SEC on 2023-09-06.
Scheduled sale ($167k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.03 | 2,100 | $63K | 37.7% |
| 2 | $30.03 | 1,737 | $52K | 31.2% |
| 3 | $30.03 | 1,737 | $52K | 31.2% |
| Total | $30.03 avg | 5,574 | $167K | 100% |
| Filing → |
| IDYA | SELL | 2023-09-14 | $30K | — | Filing → |
| IDYA | SELL | 2023-08-11 | $125K | — | Filing → |
| IDYA | SELL | 2023-07-12 | $218K | — | Filing → |